Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Daily vs Intermittent PrEP in Uganda
NCT00931346Phase 2Completed
- Sponsor
- International AIDS Vaccine Initiative
- Start
- Oct 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by International AIDS Vaccine Initiative. Started Oct 2009; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00931346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931346.